| Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed … K Patel, VS Sudhir, S Kabadi, JC Huang, S Porwal, K Thakkar, JM Pagel Journal of Oncology Pharmacy Practice 25 (8), 1897-1906, 2019 | 7 | 2019 |
| Effect of COVID-19 on bronchiectasis exacerbation rates: a retrospective US insurance claims study A Åstrand, SJ Kiddle, R Siva Ganesh Mudedla, S Porwal, K Chafekar, ... Annals of the American Thoracic Society 21 (2), 261-270, 2024 | 2 | 2024 |
| Clinical characteristics used for machine learning identification of fast progressors among patients with NASH B Reinhart, M Doherty, MM Balp, A Tietz, J Cai, S Porwal, C Kinyua, ... Hepatology 72, 45A-46A, 2020 | 1 | 2020 |
| Identification of fast progressors among patients with nonalcoholic steatohepatitis using machine learning JM Schattenberg, MM Balp, B Reinhart, S Porwal, A Tietz, MC Pedrosa, ... Gastro Hep Advances, 2023 | | 2023 |
| Effect of COVID-19 on non-cystic fibrosis bronchiectasis exacerbation rates: a retrospective claims study A Åstrand, SJ Kiddle, RSG Mudedla, S Porwal, K Chafekar, C Seminario, ... European Respiratory Journal 60 (suppl 66), 2022 | | 2022 |
| Predictive modelling to identify and characterize fast progressors among patients with non-alcoholic steatohepatitis (NASH) B Reinhart, M Docherty, MM Balp, S Régnier, A Tietz, J Cai, S Porwal, ... Journal of Hepatology 73, S403-S404, 2020 | | 2020 |
| Patient adherence and persistence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees K Patel, VS Sudhir, S Kabadi, JC Huang, S Porwal, K Thakkar, JM Pagel PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 455-456, 2019 | | 2019 |
| Patient Adherence and Persistence to Oral Targeted Therapies for Hematologic Malignancies: A Retrospective Cohort Study Among Managed Care Enrollees K Patel, VS Sudhir, S Kabadi, JC Huang, S Porwal, K Thakkar, JM Pagel Blood 132 (Supplement 1), 3534-3534, 2018 | | 2018 |
| Health Care Utilization and Costs Among Patients with Chronic Myeloid Leukemia Using Tyrosine Kinase Inhibitors JC Huang, S Karve, S Porwal, K Thakkar, T Marshall, T Rosenberg Blood 132, 3537, 2018 | | 2018 |
| Assessment of Treatment Patterns and Adverse Events Among Patients with Chronic Myeloid Leukemia Using Tyrosine Kinase Inhibitors S Karve, JC Huang, N Ranade, S Porwal, M Desai, T Rosenberg Blood 132, 3585, 2018 | | 2018 |
